Nardosinone Alleviates Parkinson's Disease Symptoms in Mice by Regulating Dopamine D2 Receptor
文献类型：期刊论文
| 作者 | Bian, Li-hua2; Yao, Zi-wei2; Zhao, Cheng-bowen2; Li, Qiu-yu2; Shi, Jin-li2; Guo, Jian-you1
|
| 刊名 | EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
 |
| 出版日期 | 2021-08-14 |
| 卷号 | 2021页码:14 |
| ISSN号 | 1741-427X |
| DOI | 10.1155/2021/6686965 |
| 通讯作者 | Shi, Jin-li(shijl@vip.sina.com) ; Guo, Jian-you(bioyou@126.com) |
| 英文摘要 | Nardostachyos Radix et Rhizoma (nardostachys) is the root and rhizome of Nardostachys jatamansi DC. Recent studies have shown that nardostachys may exert an anti-PD effect. In this study, the UHPLC-LTQ-Orbitrap-MS method was used to analyze the brain components of nardostachys in rats. Based on the results of UHPLC-LTQ-Orbitrap-MS analysis, nardosinone was identified to be the most effective anti-PD compound in nardostachys. To further verify this inference, a mouse PD model was established and the effect of nardosinone on PD mice was determined using classic behavioral tests. The results showed that nardosinone was indeed effective for relieving PD symptoms in mice. Moreover, network pharmacology analysis was used to elucidate the mechanism underlying the anti-PD effect of nardosinone. Dopamine receptor D2 (DRD2) was identified as the key target of nardosinone-PD interaction network, which was further verified by molecular docking and Western blotting. The results demonstrated that nardosinone and DRD2 could interact with each other. Furthermore, the expression level of DRD2 was decreased in the brain tissue of PD mice, and nardosinone could restore its expression to a certain extent. In conclusion, our findings suggest that nardosinone may reduce the motor and cognitive symptoms in the animal PD model by regulating DRD2 expression. |
| 收录类别 | SCI |
| WOS关键词 | NARDOSTACHYS-JATAMANSI ; NETWORK PHARMACOLOGY ; POLYMORPHISMS ; EXPOSURE ; DRD2 ; ASSOCIATION |
| 资助项目 | National Natural Science Foundation of China[81673560] |
| WOS研究方向 | Integrative & Complementary Medicine |
| 语种 | 英语 |
| 出版者 | HINDAWI LTD |
| WOS记录号 | WOS:000687476200001 |
| 资助机构 | National Natural Science Foundation of China |
| 源URL | [http://ir.psych.ac.cn/handle/311026/40113]  |
| 专题 | 心理研究所_中国科学院心理健康重点实验室 |
| 通讯作者 | Shi, Jin-li; Guo, Jian-you |
| 作者单位 | 1.Chinese Acad Sci, Inst Psychol, CAS Key Lab Mental Hlth, 4A Datun Rd, Beijing 100101, Peoples R China 2.Beijing Univ Chinese Med, Sch Chinese Mat Med, 11A North Third Ring East Rd, Beijing 100029, Peoples R China |
| 推荐引用方式 GB/T 7714 | Bian, Li-hua,Yao, Zi-wei,Zhao, Cheng-bowen,et al. Nardosinone Alleviates Parkinson's Disease Symptoms in Mice by Regulating Dopamine D2 Receptor[J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE,2021,2021:14. |
| APA | Bian, Li-hua,Yao, Zi-wei,Zhao, Cheng-bowen,Li, Qiu-yu,Shi, Jin-li,&Guo, Jian-you.(2021).Nardosinone Alleviates Parkinson's Disease Symptoms in Mice by Regulating Dopamine D2 Receptor.EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE,2021,14. |
| MLA | Bian, Li-hua,et al."Nardosinone Alleviates Parkinson's Disease Symptoms in Mice by Regulating Dopamine D2 Receptor".EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE 2021(2021):14. |
入库方式： OAI收割
来源：心理研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。